학술논문
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
Document Type
Article
Author
Delany-Moretlwe, Sinead; Lombard, Carl; Baron, Deborah; Bekker, Linda-Gail; Nkala, Busi; Ahmed, Khatija; Sebe, Modulakgotla; Brumskine, William; Nchabeleng, Maposhane; Palanee-Philips, Thesla; Ntshangase, Julius; Sibiya, Sidney; Smith, Emilee; Panchia, Ravindre; Myer, Landon; Schwartz, Jill L; Marzinke, Mark; Morris, Lynn; Brown, Elizabeth R; Doncel, Gustavo F; Gray, Glenda; Rees, Helen
Source
In The Lancet Infectious Diseases November 2018 18(11):1241-1250
Subject
Language
ISSN
1473-3099